1	¿	¿	Fia	-	-	524-525	262_QUEST_clinical_caseMIR	SENT1	-	-
2	Cuál	cuál	PT0CS000	-	-	525-529	262_QUEST_clinical_caseMIR	SENT1	-	-
3	de	de	SPS00	C0332285	atributo	530-532	262_QUEST_clinical_caseMIR	SENT1	-	-
4	las	el	DA0FP0	-	-	533-536	262_QUEST_clinical_caseMIR	SENT1	-	-
5	siguientes	siguiente	AQ0CP0	C0332282	atributo	537-547	262_QUEST_clinical_caseMIR	SENT1	-	-
6	acciones	acción	NCFP000	C0441472#C3266814	calificador#atributo	548-556	262_QUEST_clinical_caseMIR	SENT1	-	-
7	se	se	P00CN000	-	-	557-559	262_QUEST_clinical_caseMIR	SENT1	-	-
8	asocia	asociar	VMIP3S0	-	-	560-566	262_QUEST_clinical_caseMIR	SENT1	-	-
9	con	con	SPS00	C0332287	atributo	567-570	262_QUEST_clinical_caseMIR	SENT1	-	-
10	una	una		C0205447_1	calificador_1	571-574	262_QUEST_clinical_caseMIR	SENT1	-	-
11	mayor	mayor	AQ0CS0	C0205164#C1704243#C0549177	calificador	575-580	262_QUEST_clinical_caseMIR	SENT1	-	-
12	reducción	reducción	NCFS000	C0333668	anomalía_morfológica	581-590	262_QUEST_clinical_caseMIR	SENT1	-	-
13	del	del	SP+DA	-	-	591-594	262_QUEST_clinical_caseMIR	SENT1	-	-
14	riesgo	riesgo	NCMS000	C0035647_1	calificador_1	595-601	262_QUEST_clinical_caseMIR	SENT1	-	-
15	de	de	SPS00	C0035647_2	calificador_2	602-604	262_QUEST_clinical_caseMIR	SENT1	-	-
16	sufrir	sufrir	VMN0000	-	-	605-611	262_QUEST_clinical_caseMIR	SENT1	-	-
17	un	un		C0205447_1	calificador_1	612-614	262_QUEST_clinical_caseMIR	SENT1	-	-
18	accidente	accidente	NCMS000	C0038454#C1540600_1	trastorno_1	615-624	262_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
19	cerebrovascular	cerebrovascular	AQ0CS0	C0038454#C1540600_2	trastorno_2	625-640	262_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
20	?	?	Fit	-	-	640-641	262_QUEST_clinical_caseMIR	SENT1	-	-
21	:	:	Fd	-	-	641-642	262_QUEST_clinical_caseMIR	SENT1	-	-
22	Una	Una		C0205447_1	calificador_1	0-3	262_QUEST_clinical_caseMIR	SENT1	-	-
23	mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	4-9	262_QUEST_clinical_caseMIR	SENT1	-	-
24	de	de	SPS00	C0332285	atributo	10-12	262_QUEST_clinical_caseMIR	SENT1	-	-
25	27	27		-	-	13-15	262_QUEST_clinical_caseMIR	SENT1	-	-
26	años	año	NCMP000	C0439234	calificador	16-20	262_QUEST_clinical_caseMIR	SENT1	-	-
27	,	,	Fc	-	-	20-21	262_QUEST_clinical_caseMIR	SENT1	-	-
28	embarazada	embarazar	VMP00SF	-	-	22-32	262_QUEST_clinical_caseMIR	SENT1	-	-
29	de	de	SPS00	C0332285	atributo	33-35	262_QUEST_clinical_caseMIR	SENT1	-	-
30	10	10		-	-	36-38	262_QUEST_clinical_caseMIR	SENT1	-	-
31	semanas	semana	NCFP000	C0439230	calificador	39-46	262_QUEST_clinical_caseMIR	SENT1	-	-
32	y	y	CC	C1706368	calificador	47-48	262_QUEST_clinical_caseMIR	SENT1	-	-
33	con	con	SPS00	C0332287	atributo	49-52	262_QUEST_clinical_caseMIR	SENT1	-	-
34	asma	asma	NCMS000	C0004096#C0085129#C1319018#C1260881	trastorno	53-57	262_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
35	alérgico	alérgico	AQ0MS0	-	-	58-66	262_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
36	grave	grave	AQ0CS0	C0439808#C0205082	calificador	67-72	262_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
37	persistente	persistente	AQ0CS0	C0205322#C0549178	calificador	73-84	262_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
38	.	.	Fp	-	-	84-85	262_QUEST_clinical_caseMIR	SENT1	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	86-88	262_QUEST_clinical_caseMIR	SENT2	-	-
2	la	el	DA0FS0	-	-	89-91	262_QUEST_clinical_caseMIR	SENT2	-	-
3	actualidad	actualidad	NCFS000	-	-	92-102	262_QUEST_clinical_caseMIR	SENT2	-	-
4	está	estar	VAIP3S0	-	-	103-107	262_QUEST_clinical_caseMIR	SENT2	-	-
5	adecuadamente	adecuadamente	RG	-	-	108-121	262_QUEST_clinical_caseMIR	SENT2	-	-
6	controlada	controlar	VMP00SF	-	-	122-132	262_QUEST_clinical_caseMIR	SENT2	-	-
7	con	con	SPS00	C0332287	atributo	133-136	262_QUEST_clinical_caseMIR	SENT2	-	-
8	hudesonida	hudesonida	NCFS000	-	-	137-147	262_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
9	inhalada	inhalar	VMP00SF	-	-	148-156	262_QUEST_clinical_caseMIR	SENT2	-	-
10	diaria	diario	AQ0FS0	C0332173	calificador	157-163	262_QUEST_clinical_caseMIR	SENT2	-	-
11	y	y	CC	C1706368	calificador	164-165	262_QUEST_clinical_caseMIR	SENT2	-	-
12	salbutamol	salbutamol	NC00SC0	C0001927	producto	166-176	262_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
13	inhalado	inhalar	VMP00SM	-	-	177-185	262_QUEST_clinical_caseMIR	SENT2	-	-
14	a	a	SPS00	-	-	186-187	262_QUEST_clinical_caseMIR	SENT2	-	-
15	demanda	demanda	NCFS000	C0441516	calificador	188-195	262_QUEST_clinical_caseMIR	SENT2	-	-
16	de	de	SPS00	C0332285	atributo	196-198	262_QUEST_clinical_caseMIR	SENT2	-	-
17	rescate	rescate	NCMS000	-	-	199-206	262_QUEST_clinical_caseMIR	SENT2	-	-
18	.	.	Fp	-	-	206-207	262_QUEST_clinical_caseMIR	SENT2	-	-

1	Acude	acudir	VMIP3S0	-	-	208-213	262_QUEST_clinical_caseMIR	SENT3	-	-
2	a	a	SPS00	-	-	214-215	262_QUEST_clinical_caseMIR	SENT3	-	-
3	su	su	DP3CS0	-	-	216-218	262_QUEST_clinical_caseMIR	SENT3	-	-
4	consulta	consulta	NCFS000	C3543841#C0009818	metadato_fundacional#procedimiento	219-227	262_QUEST_clinical_caseMIR	SENT3	-	-
5	preocupada	preocupar	VMP00SF	-	-	228-238	262_QUEST_clinical_caseMIR	SENT3	-	-
6	por	por	SPS00	C0678226	atributo	239-242	262_QUEST_clinical_caseMIR	SENT3	-	-
7	los	el	DA0MP0	-	-	243-246	262_QUEST_clinical_caseMIR	SENT3	-	-
8	posibles	posible	AQ0CP0	C0332149#C2362652	calificador	247-255	262_QUEST_clinical_caseMIR	SENT3	-	-
9	efectos	efecto	NCMP000	C1704419#C1280500#C1280519	calificador	256-263	262_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
10	teratogénicos	teratogénico	AQ0MP0	-	-	264-277	262_QUEST_clinical_caseMIR	SENT3	I-Grp_Enfermedad	-
11	de	de	SPS00	C0332285	atributo	278-280	262_QUEST_clinical_caseMIR	SENT3	-	-
12	su	su	DP3CS0	-	-	281-283	262_QUEST_clinical_caseMIR	SENT3	-	-
13	medicación	medicación	NCFS000	C0013227	sustancia	284-294	262_QUEST_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
14	antiasmática	antiasmático	AQ0FS0	C0304440#C0282556	producto	295-307	262_QUEST_clinical_caseMIR	SENT3	I-Grp_Medicamento	-
15	.	.	Fp	-	-	307-308	262_QUEST_clinical_caseMIR	SENT3	-	-

